Astroglial Alterations in the Hippocampus of Rats Submitted to a Single Trans-Cranial Direct Current Stimulation Trial

Evidence indicates that transcranial direct current stimulation (tDCS) provides therapeutic benefits in different situations, such as epilepsy, depression, inflammatory and neuropathic pain. Despite the increasing use of tDCS, its cellular and molecular basis remains unknown. Astrocytes display a cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurochemical research 2023-11, Vol.48 (11), p.3447-3456
Hauptverfasser: Zin, Lisandra Eda Fusinato, Vizuete, Adriana Fernanda K., Callai, Etiane Micheli Meyer, Catarina, Luciana Santa, Fróes, Fernanda, Moreira, Ana Paula, de Oliveira Marques, Charlanne, Leal, Miriara B., Ponzoni, Deise, Puricelli, Edela, da Silva Torres, Iraci Lucena, Gonçalves, Carlos-Alberto, Quevedo, Alexandre Silva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Evidence indicates that transcranial direct current stimulation (tDCS) provides therapeutic benefits in different situations, such as epilepsy, depression, inflammatory and neuropathic pain. Despite the increasing use of tDCS, its cellular and molecular basis remains unknown. Astrocytes display a close functional and structural relationship with neurons and have been identified as mediators of neuroprotection in tDCS. Considering the importance of hippocampal glutamatergic neurotransmission in nociceptive pathways, we decided to investigate short-term changes in the hippocampal astrocytes of rats subjected to tDCS, evaluating specific cellular markers (GFAP and S100B), as well as markers of astroglial activity; glutamate uptake, glutamine synthesis by glutamine synthetase (GS) and glutathione content. Data clearly show that a single session of tDCS increases the pain threshold elicited by mechanical and thermal stimuli, as evaluated by von Frey and hot plate tests, respectively. These changes involve inflammatory and astroglial neurochemical changes in the hippocampus, based on specific changes in cell markers, such as S100B and GS. Alterations in S100B were also observed in the cerebrospinal fluid of tDCS animals and, most importantly, specific functional changes (increased glutamate uptake and increased GS activity) were detected in hippocampal astrocytes. These findings contribute to a better understanding of tDCS as a therapeutic strategy for nervous disorders and reinforce the importance of astrocytes as therapeutic targets. Highlights tDCS has many proposed therapeutic uses, but its mechanism of action remains unclear. There is some evidence to suggest the involvement of glial cells in the effect of tDCS. A single tDCS increases the pain threshold elicited by mechanical and thermal stimuli. This mechanism involves inflammatory and astroglial changes in the hippocampus. Increased glutamate uptake and GS activity confirm the astroglial functionality changes.
ISSN:0364-3190
1573-6903
DOI:10.1007/s11064-023-03990-0